Novel pyrazole inhibitors for discrimination between receptor-operated and store-operated Ca2+ entry

IF 2.9 3区医学 Q2 Medicine

BMC Pharmacology & Toxicology Pub Date : 2011-09-05 DOI:10.1186/1471-2210-11-S2-A18

H. Schleifer, R. Oppenrieder, Sonia Stürmer, B. Doleschal, M. Poteser, T. Glasnov, C. Kappe, K. Groschner

引用次数: 0

查看原文本刊更多论文

新型吡唑抑制剂区分受体操作和储存操作的Ca2+进入

本文章由计算机程序翻译，如有差异，请以英文原文为准。

求助全文

约1分钟内获得全文求助全文

来源期刊

BMC Pharmacology & Toxicology PHARMACOLOGY & PHARMACY-TOXICOLOGY

CiteScore

4.40

自引率

0.00%

发文量

审稿时长

12 weeks

期刊介绍： BMC Pharmacology and Toxicology is an open access, peer-reviewed journal that considers articles on all aspects of chemically defined therapeutic and toxic agents. The journal welcomes submissions from all fields of experimental and clinical pharmacology including clinical trials and toxicology.